Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

von Hippel-Lindau development in children and adolescents

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Clinical characteristics and quality of life, depression, and anxiety in adults with neurofibromatosis type 1: A nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. First reported adult patient with TARP syndrome: A case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Ocular albinism with infertility and late-onset sensorineural hearing loss

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Stakeholders in psychiatry and their attitudes toward receiving pertinent and incident findings in genomic research

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Trisomy 8 mosaicism in the placenta: A Danish cohort study of 37 cases and a literature review

    Research output: Contribution to journalReviewpeer-review

  2. The Phenotypic Spectrum of PRRT2-Associated Paroxysmal Neurologic Disorders in Childhood

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Haploinsufficiency of ARHGAP42 is associated with hypertension

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Karoline Launbjerg
  • Iben Bache
  • Michael Galanakis
  • Marie Luise Bisgaard
  • Marie Louise M Binderup
View graph of relations

The autosomal dominant von Hippel-Lindau disease (vHL) is associated with a lifelong risk of tumor development, especially retinal and CNS hemangioblastomas, pheochromocytoma, and renal cell carcinoma. Knowledge of paediatric vHL development is limited, and current surveillance guidelines are based on expert opinions. We aimed to describe the course of vHL development in children and adolescents, focusing on age at first manifestation, manifestation frequencies, and types. The prevalence of vHL diagnosis as well as manifestations in childhood were evaluated based on 99 patients, who had started surveillance before 18 years: 37 Danish patients from the national vHL research database and 62 international patients reported in 15 articles. Overall, 70% (69 of 99) developed manifestations before 18 years (median age at first manifestation: 12 years (range: 6-17 years)). Thirty per cent (30 of 99) had developed more than one manifestation type; the most frequent were retinal (34%) and CNS (30%) hemangioblastomas. Among the 37 Danish patients, 85% (97 of 116) of their tumors were asymptomatic. Vision outcome is significantly improved in hemangioblastomas that are treated while still asymptomatic. We agree with current guidelines that retinal surveillance be performed from birth. The patients had their first CNS hemangioblastomas at the median ages of 13-14 years (range: 6-17 years). Further, 11% (4 of 37) of the Danish patients had CNS surgery in their teenage years. Although the cohort is too small to make definite conclusions about specific initiation ages, regular CNS surveillance from vHL patients' teenage years seems clinically relevant.

Original languageEnglish
JournalAmerican Journal of Medical Genetics, Part A
Volume173
Issue number9
Pages (from-to)2381-2394
Number of pages14
ISSN1552-4825
DOIs
Publication statusPublished - Sep 2017

    Research areas

  • Adolescent, Central Nervous System Neoplasms, Child, Denmark, Female, Hemangioblastoma, Humans, Male, von Hippel-Lindau Disease, Journal Article

ID: 52672579